Oncolytics Biotech (ONCY) Posts Wider Q4 Loss

Oncolytics Biotech (NASDAQ: ONCY) reported Q4 EPS of ($0.49), $0.39 worse than the analyst estimate of ($0.10).

For earnings history and earnings-related data on Oncolytics Biotech (ONCY) click here.

You May Also Be Interested In

• Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
• Energy Fuels to acquire rare earth magnet maker VAC for $1.9 billion
• FirstCash to acquire UK pawn operator Ramsdens for £206 million